The breastmilk of mothers in Bangladesh who received the meningococcal vaccine during pregnancy had anti-meningococcal antibody levels at 3-6 months after delivery of four to five times higher than that of mothers who did not receive the vaccine.
Although this study was published in 2002, the data on this topic are sparse as it is methodologically difficult to conduct studies to evaluate the relationship between anti-meningococcal antibodies in breastmilk and protection.
Full Citation:
Shahid NS, Steinhoff MC, Roy E et al.. 2002. Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococal vaccine: a randomized, controlled evaluation. Vaccine. 20(17-18).
Title of Article: Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococal vaccine: a randomized, controlled evaluation
Author(s): Shahid NS, Steinhoff MC, Roy E et al.
Publication Year: 2002
Publication Name: Vaccine
Publication Volume: 20(17-18)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/12009297/
DOI (Digital Object Identifier): 10.1016/s0264-410x(02)00061-0
Topics: Health
Disease Vaccines: Meningococcal disease / MenACWY
Immunization Terms: Maternal immunization
Countries: Bangladesh
WHO Regions: South-East Asia